Redmile Group, LLC - 10%+ Owner at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
TRDA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Redmile Group, LLC since 11/5/2023

Holdings reported by Redmile Group, LLC for Entrada Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.95M $31.3M $15.99 Nov 2, 2021 Indirect
Series B Convertible Preferred Stock 0 Nov 2, 2021 Indirect Common Stock

Transactions reported by Redmile Group, LLC for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.